2021

Friday 3 December 2021

We are looking for an enthusiastic early career researcher to join our team to work on the UKRI Youth LIVES (LIVed experience in Evidence Synthesis) programme. This is a split role between CRD and Stockholm Environment Institute (SEI) at York, to enable the appointee to benefit from working with both health research experts and citizen science experts.

Wednesday 29 September 2021

We are recruiting a Senior Research Fellow to lead projects, provide advanced statistical guidance and develop methods for use in evidence synthesis.

Monday 6 September 2021

CRD staff including Bob Phillips and Jess Morgan have completed a series of studies about managing a common complication of cancer therapy in children called 'febrile neutropenia'.

Tuesday 9 March 2021

CRD researchers will carry out one of the first studies in the UKRI Citizen Science Collaboration programme.

Tuesday 9 March 2021

We are delighted that Dr Jess Morgan has been included among 15 inspirational women featured in a book published British Medical Association’s Women in Academic Medicine Group women to celebrate International Women’s Day 2021.

Friday 26 February 2021

NIHR has commissioned a randomised trial following a CRD review on phantom limb pain.

Tuesday 16 February 2021

This month PROSPERO celebrates ten years since its launch in February 2011. Since then PROSPERO has proved highly successful in persuading researchers to register their systematic review protocols.

Wednesday 10 February 2021

Paediatric cancer patients who test positive for COVID-19 do not appear to be at any increased risk of severe COVID-19 infection compared with healthy children, a new study shows.

Wednesday 27 January 2021

Congratulations to CRD Research Fellow Lucy Beresford who has been awarded the MSc Applied Health Research Outstanding Taught Postgraduate Academic Achievement Prize by the Department of Health Sciences at the University of York.

Thursday 14 January 2021

CRD Clinical Academic Dr Bob Phillips is leading a new study to understand treatment decision-making processes in families where a child or young person has relapsed/refractory rhabdomyosarcoma. The study is funded by the Children’s Cancer and Leukaemia Group (CCLG) Special Named Funds.